GeneBio Launches SmileMS 0.9 at Swiss MedLab International Congress
Complete the form below to unlock access to ALL audio articles.
Geneva Bioinformatics (GeneBio) SA has announced the expansion of its existing mass spectrometry (MS)-based offering with the public launch of version 0.9 of SmileMS, its solution to screen large sets of molecules with high confidence.
SmileMS is a software platform for the identification and analysis of small molecules by mass spectrometry. Developed in collaboration with the Swiss Institute of Bioinformatics (SIB) and Prof. Denis Hochstrasser’s group at the Geneva University Hospitals, SmileMS is a solution that targets an unmet yet growing need for automatable processes using LC-MS techniques for routine daily analysis of small molecules.
The company has already announced at ASMS 2008 its endeavor in this new field, and is coming now, less than 4 months after, with a first version that has already been successfully tested and implemented for a broad range of applications like Clinical Chemistry, Toxicology, Food Testing as well as Legal Medicine and that can be extended to other fields such as Doping, Therapeutic Drug Monitoring and other needs in laboratory medicine.
The company claims that SmileMS comprises a plethora of features, including:
• Instrument-Independent Algorithm
• Designed to be instrument-vendor-independent, thus handling data acquired on different types of mass spectrometers
• Highly sensitive algorithm, even when searching libraries generated from a different instrument or under other acquisition settings
• Robust statistics-based kernel
• Features high-end discrimination power
• Flexible Web Interface
• Simple analysis workflows: prepare a submission - evaluate results - generate customizable reports
• Results provided in various flavors, including molecule-centric and spectrum-centric views
• Dedicated roles and privileges for each user
• Client-server architecture allowing remote access to check and validate results
• Dedicated batch submission system to automate analyses processes
• Enhanced Sharing of Spectra Libraries
• Full integration of NIST LC-MS/MS spectra library
• Reference library creation and maintenance feature that allow the seamless further integration of private (Weinmann, Marquet, etc.) or public libraries
• Share and search reference spectra libraries between collaborating laboratories
• A wide Range of Applications
• Successfully tested on data acquired on a wide variety of MS instruments
• Already used in toxicology analysis in clinics and forensic applications, and is being tested in food control and doping laboratories
“SmileMS is positioning GeneBio beyond its historical proteomics business and opens the gate to a wide variety of new applications and developments in the field of mass spectrometry that we are eager to discover with our partners,” said Nasri Nahas, CEO of GeneBio.
